← Back to Clinical Trials
Recruiting NCT05881616

NCT05881616 Study on Serum Metabolomics of GDM

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05881616
Status Recruiting
Phase
Sponsor Zhejiang University
Condition GDM
Study Type OBSERVATIONAL
Enrollment 480 participants
Start Date 2023-07-18
Primary Completion 2026-05

Trial Parameters

Condition GDM
Sponsor Zhejiang University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 480
Sex FEMALE
Min Age 20 Years
Max Age 40 Years
Start Date 2023-07-18
Completion 2026-05
Interventions
Specimen samples and baseline data collectionSpecimen samples and baseline data collectionSpecimen samples and baseline data collection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to collect serum samples from healthy non-pregnant women, pregnant women with and without Gestational Diabetes Mellitus (GDM). We will analyze the metabolite changes among the three groups using clinical metabolomics and identify potential biomarkers and metabolic pathways. This study will provide scientific evidence for early clinical diagnosis, prevention, control, and treatment research of GDM.

Eligibility Criteria

Inclusion Criteria: * No obvious abnormalities in all inspection items * No history of diabetes * No particular dietary habits * No previous history of other mental illnesses * No history of drug abuse or allergies * No history of smoking or drinking Exclusion Criteria: * Pregnancy complications such as uterine fibroids, hyperthyroidism/hypothyroidism, and antiphospholipid antibody syndrome * Critical illnesses such as cardiovascular disease or abnormal liver/kidney function * Personal history of syphilis, HIV positive, and other infectious diseases * Artificial insemination or IVF pregnancy * Multiple pregnancy (twins or more) * Patients participating in other clinical studies * Other reasons that researchers think are inappropriate

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology